Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
Clinical trial NCT04547140 · TERMINATED
Trial details
- NCT number
- NCT04547140
- Sponsor
- Grifols Therapeutics LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-29
- Primary completion
- 2021-12-13
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.